Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP) is a receptor-type protein tyrosine phosphatase predominantly expressed in vascular endothelial cells. It plays a crucial role in regulating angiogenesis, vascular permeability, and the integrity of endothelial cell junctions. VE-PTP acts by dephosphorylating key substrates like VE-cadherin and Tie2, influencing cell adhesion, signaling pathways, and vascular remodeling. Dysregulation of VE-PTP is implicated in various diseases, including cancer and inflammatory conditions, making it a potential therapeutic target for modulating angiogenesis and vascular function.
Dephosphorylates tyrosine residues on target proteins, such as VE-cadherin and Tie2, to regulate their activity and downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Endothelial-Protein Tyrosine Phosphatase (VE-PTP).